FDA could give full approval for Pfizer vaccine by September

The Food and Drug Administration (FDA) is aiming to give full approval for the Pfizer COVID-19 vaccine by early September, The New York Times reported on Tuesday, citing people involved in the effort.

The FDA gave emergency use authorization to the Pfizer vaccine late last year. Full approval by could push more Americans to get the COVID-19 vaccine.